Evidence map›Paper›PMID 40974138›Full record

ArticleInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2026

Cardiovascular risk profile according to World Health Organization medical eligibility criteria for contraceptive use of women using hormonal contraception in Rio de Janeiro state, Brazil.

Isabela Pereira Fonseca Brusth, Juliana Montani Raimundo, Helene Nara Henriques Blanc

Abstract read
In one paragraph

Article in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Isabela Pereira Fonseca BrusthPathophysiology Laboratory, Federal University of Rio de Janeiro - Multidisciplinary Center UFRJ Macaé, Rio de Janeiro, Brazil.ORCID https://orcid.org/0000-0002-6553-0331
Juliana Montani RaimundoResearch Group in Pharmacology of Bioactive Products, Federal University of Rio de Janeiro - Multidisciplinary Center UFRJ Macaé, Rio de Janeiro, Brazil.ORCID https://orcid.org/0000-0001-9152-4931
Helene Nara Henriques BlancPathophysiology Laboratory, Federal University of Rio de Janeiro - Multidisciplinary Center UFRJ Macaé, Rio de Janeiro, Brazil.ORCID https://orcid.org/0000-0001-5729-9785

Funding

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/203.043/2019
6 · The paper itself

Abstract

objectiveHormonal contraception, especially combined oral contraceptives, is associated with an increase in cardiovascular risk. Thus, we aimed to analyze the use of hormonal contraceptive methods in the state of Rio de Janeiro (Brazil), with a focus on determining whether contraceptive use follows the cardiovascular profile of women according to the World Health Organization Medical Eligibility Criteria for Contraceptive Use (MEC).

methodsThis was a descriptive cross-sectional study based on a self-completed online survey about information concerning socioeconomic status, cardiovascular profile, and hormonal contraceptive use. A total of 501 responses were evaluated.

resultsCombined oral contraceptive was the choice of 58.97% of participants. Our data show that 88.27% of participants presented at least one cardiovascular risk factor, with sedentary lifestyle, overweight, and obesity being the most prevalent. Regarding cardiovascular risk factors considered in MEC, 81.60% of participants use the appropriate contraceptive for their health. Most women reported using the contraceptive with a prescription, including 83.33% of participants in categories 3 and 4, which represent contraindications for hormonal contraceptive use according to MEC.

conclusionAlthough most women living in Rio de Janeiro use an appropriate hormonal contraceptive, clinical management and cardiovascular risk assessment must be improved to protect women's health and ensure an evidence-based family planning strategy.

Indexed as

Cardiovascular DiseasesContraception BehaviorContraceptives, Oral, HormonalHeart Disease Risk FactorsHormonal ContraceptionAdolescentAdultBrazilCross-Sectional StudiesEligibility DeterminationFemaleHumansMiddle AgedRisk FactorsSurveys and QuestionnairesWorld Health OrganizationContraceptives, Oral, Hormonalcardiovascular profilehormonal contraceptionwomen's health

Identifiers

PMID40974138
PMCPMC12936646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.